Related Experiment Videos
Progressive systemic sclerosis preceded by malignant lymphoma
T Yamamoto1, Y Furuse, K Nishioka
1Department of Dermatology, Kiryu Kosei General Hospital, Gunma, Japan.
The Journal of Dermatology
|October 1, 1993
Summary
This case study highlights a rare instance of malignant lymphoma preceding progressive systemic sclerosis (PSS). While treatment led to remission, the patient later succumbed to respiratory failure, suggesting complex immune interplay.
Area of Science:
- Immunology
- Oncology
- Rheumatology
Background:
- Progressive systemic sclerosis (PSS) is a chronic autoimmune disease.
- Malignant lymphoma is a cancer of the lymphatic system.
- The association between PSS and malignant lymphoma is documented, but typically PSS precedes lymphoma.
Observation:
- A patient developed PSS two years after diagnosis of jejunal malignant lymphoma.
- The patient underwent surgical resection and VEMP chemotherapy, achieving remission.
- Five years post-treatment, the patient died from acute respiratory failure.
Findings:
- This case presents a rare scenario where malignant lymphoma occurred before the onset of PSS.
- Immune abnormalities, including high-titer antinuclear factor and positive anti-RNP antibodies, were observed.
- These immune markers are suspected contributors to the development of PSS in this patient.
Implications:
- This case underscores the complex and varied relationship between autoimmune diseases and hematologic malignancies.
- Understanding the immune dysregulation in such cases may offer new therapeutic targets for both PSS and lymphoma.
- Further research into antecedent lymphoma in PSS patients is warranted to elucidate underlying mechanisms.